PPBT (Purple Biotech Ltd. American Depositary Shares) Stock Analysis - Insider Trades

Purple Biotech Ltd. American Depositary Shares (PPBT) is a publicly traded Healthcare sector company. As of May 21, 2026, PPBT trades at $2.81 with a market cap of $3.51M and a P/E ratio of 0.00. PPBT moved -11.11% today. Year to date, PPBT is -57.03%; over the trailing twelve months it is -87.63%. Its 52-week range spans $2.71 to $139.50. Analyst consensus is buy with an average price target of $30.00. Rallies surfaces PPBT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading PPBT stock inside the company?

Rallies tracks PPBT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

PPBT Key Metrics

Key financial metrics for PPBT
MetricValue
Price$2.81
Market Cap$3.51M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$139.50
52-Week Low$2.71
Volume10.14K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest PPBT News

PPBT Analyst Consensus

1 analysts cover PPBT: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $30.00.

Common questions about PPBT

Who is trading PPBT stock inside the company?
Rallies tracks PPBT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for PPBT?
Yes. Rallies tracks PPBT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PPBT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PPBT. It does not provide personalized investment advice.
PPBT

PPBT